BLPH News and Press, Bellerophon Therapeutics Inc. From 03/20/23

2023-03-20 10:29:09 ET Gainers: Lifecore Biomedical ( LFCR ) +41% . Connect Biopharma ( CNTB ) +27% . InMed Pharmaceuticals ( INM ) +21% . ReShape Lifesciences ( RSLS ) +21% . Bellerophon Therapeutics ( BLPH ) +15% . Losers...

2023-03-08 08:46:06 ET Intelligent Bio Solutions ( INBS ) -48% on proposed public offering . Castor Maritime ( CTRM ) -36% . Miromatrix Medical ( MIRO ) -32% on pricing $10M stock offering . United Natural Foods ( UNFI ) -22% on Q2...

2023-03-06 13:05:55 ET Gainers: Bellerophon ( BLPH ) +86% . Ambrx Biopharma ( AMAM ) +69% . BridgeBio Pharma ( BBIO ) +56% . Avalon GloboCare ( ALBT ) +47% . Azul ( AZUL ) +42% . TCR2 Therapeutics ( TCRR ) +38% . ...

2023-03-06 08:44:37 ET Bellerophon Therapeutics ( NASDAQ: BLPH ) entered into a subscription agreement with a life sciences-focused institutional investor to sell, in a registered direct offering, 718,474 shares at $2/share and 1.78M prefunded warrants at a price of ...

WARREN, N.J., March 06, 2023 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced that it has entered ...

Gainers: Cardio Diagnostics ( CDIO ) +135% . Bioventus ( BVS ) +64% . Sky Harbour Group ( SKYH ) +36% . RenovoRx ( RNXT ) +24% . Bellerophon ( BLPH ) +24% . SI-BONE ( SIBN ) +23% . Chico's FAS ( CHS ) +21% . Kon...

Bellerophon Therapeutics ( NASDAQ: BLPH ) announced the clearance of its Investigational New Drug ( IND ) application to conduct a Phase 3 clinical trial of INOpulse to treat fibrotic interstitial lung disease (fILD) in China. ( BLPH ) is trading 4.2% higher prem...

WARREN, N.J., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today announced clearance of its Inve...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Now’s a great time to start considering which micro-cap stocks to buy. Generally, micro-caps are stocks with a market capitalization of less than $300 million. With a cap like that, the company doesn’t have a to...

Bellerophon Therapeutics ( NASDAQ: BLPH ) is up 14% in after-hours trading on Thursday after the company completed enrollment in a phase 3 study of INOpulse, a pulsatile nitric oxide delivery system, for fibrotic interstitial lung disease. The 145-patient trial is designed to meas...